Berlin analytics SME with hands-on experience in neonatal health research networks and university-enterprise knowledge transfer projects.
MOKI Analytics is a Berlin-based data analytics SME that contributes industry-side expertise and analytical capabilities to European research consortia. Their most substantive project involvement is in the GROWTH MSCA Innovative Training Network, focused on early life nutrition and neonatal pathologies — conditions including intestinal failure, sepsis, and necrotizing enterocolitis — where they likely provide data analysis, research translation, or industry training placements for early-career researchers. As a third party in the CEMBO coordination action, they appear to support institutional capacity-building efforts linking universities and enterprises. The "Analytics" in their name, combined with their role as an industry actor in health research networks, suggests their core value proposition is turning complex research or clinical data into usable business or scientific intelligence.
Participated in GROWTH (2019-2024), an MSCA-ITN specifically targeting research and training on early life nutrition to prevent intestinal failure, sepsis, and necrotizing enterocolitis.
Served as third party in CEMBO (2020-2023), a coordination action focused on university-enterprise partnerships and building research excellence capacity.
The company name 'MOKI Analytics' and their recurring role as an industry partner in research training networks suggests applied data analytics as a cross-cutting competence across both projects.
MOKI's two H2020 engagements ran nearly concurrently (2019-2024 and 2020-2023), so the keyword shift reflects a difference in project type rather than a clean chronological evolution. Their first recorded involvement centers on specific clinical conditions in neonatal medicine — a technically deep, domain-specific focus. Their second engagement shifts to institutional and process-level themes: building research prestige, talent development, and university-enterprise collaboration. This suggests MOKI is broadening its value proposition from domain-specific analytics toward a wider role as an industry bridge partner in research capacity-building initiatives.
MOKI appears to be evolving from a niche clinical-data analytics role toward a broader function as an industry connector in research excellence and training networks, which may make them a useful partner in MSCA or institutional coordination projects beyond health.
MOKI has never led a project as coordinator — they join as participant or third party, consistently in a supporting or specialist role. With only 8 unique partners across 2 projects and 5 countries, their network is small but multi-national, suggesting selective engagement rather than broad consortium activity. This profile is typical of a boutique SME that joins well-matched consortia for a defined contribution rather than seeking leadership or large-scale partnership webs.
MOKI has collaborated with 8 unique partners across 5 countries through their two H2020 projects. Their network is modest in size, consistent with a small SME that participates in targeted, specialized consortia rather than broad multi-partner alliances.
MOKI occupies an unusual niche as an analytics SME embedded in MSCA training and coordination networks — a rare combination that gives them credibility both as an industry training host and as a data-capable partner for research consortia. Their direct exposure to neonatal health research through GROWTH means they carry domain knowledge that most analytics firms lack. For consortium builders seeking an industry partner that understands both data pipelines and the academic research process, MOKI's dual-project profile signals genuine integration into the EU research ecosystem rather than token participation.
